BioMedNewsBreaks — HealthLynked Corp. (OTCQB: HLYK) Launches Enterprise Healthcare Solutions Website and Upgrades Provider Directory

HealthLynked (OTCQB: HLYK), a pioneer in healthcare technology and patient engagement, announced the launch of its newly designed Enterprise Healthcare Solutions Website, www.hlykgroup.com, and significant enhancements to its national provider directory. The new platform serves as a centralized hub for insurance carriers, pharmaceutical companies, marketing firms, ACOs, healthcare networks, and large employers, offering tools for patient engagement, population health, clinical research, coordinated care, and cost management. Upgrades to the consumer-facing provider directory include faster performance and localized provider suggestions, giving patients improved flexibility and transparency in selecting care. CEO Dr. Michael Dent said the developments reflect HealthLynked’s expanding role in the healthcare ecosystem and its commitment to scalable solutions that improve outcomes and reduce costs.

To view the full press release, visit https://ibn.fm/0LL9e

About HealthLynked Corp.

HealthLynked Corp. is committed to improving global healthcare by facilitating the efficient exchange of medical information between patients and providers. The company’s network empowers members to actively manage their healthcare through a centralized and secure platform. For more information about HealthLynked Corp., please visit www.healthlynked.com.

NOTE TO INVESTORS: The latest news and updates relating to HLYK are available in the company’s newsroom at https://ibn.fm/HLYLK

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN